Novozymes A/S
CSE:NZYM B
Novozymes A/S
CSE:NZYM B
Price:
403 DKK
-3.93%
Market Closed
Updated:
May 15, 2024
Novozymes A/S
Operating Income
|
Novozymes A/S
Operating Income Peer Comparison
Comparables:
CHR
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Novozymes A/S
CSE:NZYM B
|
Operating Income
kr4.5B
|
CAGR 3-Years
7%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Chr Hansen Holding A/S
CSE:CHR
|
Operating Income
€358.3m
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
6%
|
See Also
What is Novozymes A/S's Operating Income?
Operating Income
4.5B
DKK
4.5B
DKK
Based on the financial report for Dec 31, 2023, Novozymes A/S's Operating Income amounts to 4.5B DKK.
What is Novozymes A/S's Operating Income growth rate?
Operating Income CAGR 5Y
1%
1%
Over the last year, the Operating Income growth was 0%. The average annual Operating Income growth rates for Novozymes A/S have been 7% over the past three years , 1% over the past five years .
You don't have any saved screeners yet
